Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men

In this review of the literature, the current knowledge of ovarian, breast, and metabolic changes observed following gender-affirming hormone therapy in transgender men is discussed.
Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men

VOLUME 116, ISSUE 4, P936-942

Authors:

Paul Pirtea, M.D., Jean Marc Ayoubi, M.D., Ph.D., Stephanie Desmedt, M.D., Ph.D., Guy T’Sjoen, M.D., Ph.D.

Abstract:

Gender-affirming hormone therapy (GAHT) is often provided to transgender people. In this review of the literature, the current knowledge of ovarian, breast, and metabolic changes (body composition, insulin resistance, bone density, cardiovascular risk factors such as lipids, blood pressure, and hematocrit) observed following GAHT in adult transgender men is discussed.